ALLISON RODGERS: Open Payments
NPI 1902567985 · HANNIBAL, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 30 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $109 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $173 |
| Amgen Inc. | 4 | $59 |
| Dexcom, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $38 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Boston Scientific Corporation | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $16 |
Products named: Ozempic, Dexcom G6 Transmitter, OTEZLA, VRAYLAR, Wegovy, Rybelsus, CAPLYTA, WATCHMAN Access System.
Industry payments across MO — which companies pay providers there.
